REKLAMA

SOPHARMA AD: Notification from "Telso" AD under Regulation 596/2014 for the acquisition of warrants with ISIN № BG9200003259

2026-03-10 15:04
publikacja
2026-03-10 15:04
Dodaj Bankier.pl w Google
Spis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załączników:
  1. Telso AD_Sopharma_warrants_7years_EN_09.03.2026.pdf

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No

102

/

2026

Date of issue:

2026-03-10

Short name of the issuer

SOPHARMA AD

Subject

Notification from "Telso" AD under Regulation 596/2014 for the acquisition of warrants with ISIN № BG9200003259

Official market - legal basis

Art. 56. 1. 2 of Act on Public Offering

Unofficial market - legal basis

Contents of the report:

Notification from "Telso" AD under Regulation 596/2014 for the acquisition of warrants with ISIN № BG9200003259

Annexes

File

Description

Telso AD_Sopharma_warrants_7years_EN_09.03.2026.pdf

Notification from "Telso" AD under Regulation 596/2014 for the acquisition of warrants with ISIN № BG9200003259

SOPHARMA AD

(fullname of the issuer)

SOPHARMA AD

Farmaceutyczny (far)

(short name of the issuer)

(sector according to clasification

of the WSE in Warsow)

1220

Sofia

(post code)

(city)

IlienskoShosse

16

(street)

(number)

+359 2 813 42 00

+359 2 936 02 86

(phone number)

(fax)

(e-mail)

(web site)

nd

(NIP)

(REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Date

Name

Position / Function

Signature

2026-03-10

Ognian Ivanov Donev

Executive Director

Dodaj Bankier.pl w Google
Źródło:Komunikaty spółek (ESPI)
Tematy

Komentarze (0)

dodaj komentarz

Powiązane:

Polecane

Najnowsze

Popularne

Ważne linki